The obstetrical consequences of ischemic stroke in women of childbearing age

Jeremy David , Helene Desmurs-Clavel , Laura Mechtouff , Anne Long
Archives of Gynecology and Obstetrics 1 -8

2024
Thrombin generation and implications for hemophilia therapies: A narrative review

Robert F Sidonio Jr , Maureane Hoffman , Gili Kenet , Yesim Dargaud
Research and Practice in Thrombosis and Haemostasis 7 ( 1) 100018 -100018

6
2023
The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.

ME Mancuso , C Bidlingmaier , JN Mahlangu , M Carcao
Journal of Thrombosis and Haemostasis 16 ( 10) 2106 -2110

5
2018
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective

Wolfgang Miesbach , Manuel Carcao , Johnny Mahlangu , Yesim Dargaud
Haemophilia 30 ( 2) 257 -266

1
2024
Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding

Alexandre Leuci , Nathalie Enjolras , Muriel Marano , Melanie Daniel
Journal of Thrombosis and Haemostasis 22 ( 3) 700 -708

1
2024
Stromal cell‐derived factor 1 alpha (SDF‐1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy

Alexandre Leuci , Mélanie Robert , Laurie Josset , Muriel Marano
International Journal of Rheumatic Diseases 27 ( 2) e15061 -e15061

2024
iTRAQ strategy to quantify and identify phosphorylation level of biologically active human factor IX used for the treatment of hemophilia B

Sylvie Michelland , Nathalie Enjolras , Yesim Dargaud , Alice Indalecio
HAEMOPHILIA 20 21 -22

2014
Tailoring a specific medical leadership development program for faculty members: the Lyon-Ottawa experience

Claire Falandry , Justine Bacchetta , Muriel Doret-Dion , Carole Ferraro-Peyret
Medical Education Online 29 ( 1) 2308955 -2308955

1
2024
Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

Kathelijn Fischer , Riitta Lassila , Flora Peyvandi , Alexander Gatt
Research and practice in thrombosis and haemostasis 8 ( 4) 102461 -102461

1
2024
Liver health in hemophilia in the era of gene therapy

Yesim Dargaud , Massimo Levrero , François Bailly , Anne Lienhart
Thrombosis Research 240 109064 -109064

2024
HTRS2023. O8C. 2 Eptacog beta efficacy and safety in underweight, normal weight, and overweight/obese persons with hemophilia A or B and inhibitors

Amina Rafique , Alok Srivastava , Yasmina Abajas , Suchitra Acharya
Research and Practice in Thrombosis and Haemostasis 7 100219 -100219

2023
44
2006
Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France

Christine Vinciguerra , Christophe Zawadzki , Yesim Dargaud , Gilles Pernod
Thrombosis and haemostasis 95 ( 04) 593 -599

25
2006
Whole F8 gene sequencing combined with splicing functional analyses led to a substantial increase of the molecular diagnosis yield for non‐severe haemophilia A

Amy Dericquebourg , Mathilde Fretigny , Alexandre Leuci , Christophe Zawadzki
Haemophilia 29 ( 5) 1320 -1333

5
2023
EPTACOG BETA EFFICACY AT 24 HOURS POSTINFUSION FOR MILD OR MODERATE BLEEDS IN INDIVIDUALS WITH HEMOPHILIA A OR B AND INHIBITORS

Lisa Boggio , Maria Elisa Mancuso , Suchitra Acharya , Santiago Bonanad
AMERICAN JOURNAL OF HEMATOLOGY 98 E13 -E13

1
2023